We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
1d
GlobalData on MSNTakeda broadens its deal with BridGene for up to $770mBridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket ...
Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...
We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...
The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of novel therapeutics,” said Jasbir S. Seehra, Ph.D., Chair and Chief Executive ...
Privately-held BridGene Biosciences has announced a strategic collaboration and licensing agreement with Japan’s Takeda. The ...
Julie Kim, president of the company's U.S. unit, was named to succeed Weber in June 2026. Weber, one of the highest-profile foreign CEOs in Japan, spearheaded Takeda's $59 billion takeover of ...
(HealthDay News) — Maternal health in pregnancy is associated with offspring autism, and these associations are largely attributed to familial confounding, according to a study published online Jan.
In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other Japanese stocks. As the dangers of natural disasters increase and ...
Takeda Pharmaceutical Stock Up 1.6 % Shares of Takeda Pharmaceutical stock opened at $14.08 on Friday. Takeda Pharmaceutical Company Limited has a 1-year low of $12.57 and a 1-year high of $15.08 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results